Dynamic Technology Lab Private LTD Ligand Pharmaceuticals Inc Transaction History

Dynamic Technology Lab Private LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$80.55 - $106.05 $343,062 - $451,666	-4,259 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$89.56 - $126.72 $381,436 - $539,700	4,259 New	4,259 $406,000
Q1 2019 May 13, 2019	SELL	$105.93 - $142.47 $391,941 - $527,139	-3,700 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $474,932 - $1.01 Million	3,700 New	3,700 $502,000
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $256,372 - $333,230	-1,214 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$150.77 - $207.98 $28,193 - $38,892	-187 Reduced 13.35%	1,214 $251,000
Q1 2018 May 14, 2018	BUY	$138.63 - $182.62 $194,220 - $255,850	1,401 New	1,401 $231,000

259

18M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.98B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.